While counterintuitive that reduced tau aggregation would be associated with increased tauopathy risk, neuronal loss and cognitive impairment were reported in the absence of insoluble tau deposition in an A152T transgenic mouse model [19], implicating soluble tau species in the neurodegenerative phenotype. The gene discussed is MAPT; the disease is Cognitive impairment.